Related Experiment Video
Updated: Jul 18, 2026
07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours
I Van der Auwera1, Y Cao, J C Tille
1Translational Cancer Research Group Antwerp, Laboratory of Pathology, University of Antwerp/University Hospital Antwerp, Edegem 2650, Belgium.
British Journal of Cancer
|November 23, 2006
Summary
Quantifying lymphangiogenesis, the growth of lymphatic vessels, is crucial for cancer metastasis research. Standardizing immunohistochemical methods is needed to reduce variability and improve clinical utility for patient survival assessment.
Area of Science:
- Oncology
- Pathology
- Vascular Biology
Background:
- The lymphatic system is a key route for cancer metastasis.
- Lymphangiogenesis (lymphatic vessel growth) is linked to patient survival in various cancers.
- Current quantification methods for lymphatic vessel density exhibit significant observer variability.
Framework:
- This consensus report proposes standardizing the immunohistochemical assessment of lymphangiogenesis.
- The goal is to establish a reliable technique for quantifying lymphatic vessels in tumors.
- Standardization aims to reduce intra- and interobserver variability in lymphangiogenesis assessment.
Implementation:
- Focus on the immunohistochemical (IHC) method for lymphangiogenesis evaluation.
- Initiate a discussion on best practices for IHC-based lymphangiogenesis quantification.
- Address the need for reproducible and reliable measurement of tumor lymphatic vessels.
Implications:
- A standardized method will enable lymphangiogenesis to become a clinically useful prognostic parameter.
- Improved quantification can lead to better patient survival predictions.
- This work aims to enhance the clinical relevance of lymphangiogenesis research in oncology.
